Yearly Archives: 2026

The Department of Health and Social Care (DHSC) has today (03/03/2026) confirmed the following final list of price concessions for February 2026: Drug Pack size Price concession Aqueous cream 100 £0.99 Aqueous cream 500 £5.80 Clarithromycin 125mg/5ml oral suspension 70 £11.10 (previously £9.59) Lofepramine 70mg tablets 56 £24.86 (previously £23.89) Trimethoprim 100mg tablets 28 £4.07 (previously [...]

The post February 2026 Price Concessions Final Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has entered consultation with Community Pharmacy England on the 2026/27 Community Pharmacy Contractual Framework (CPCF). A letter signalling the start of the formal negotiations process was sent to Community Pharmacy England this week. Detailed discussions begin immediately and will cover funding, service changes and other arrangements for [...]

The post Negotiations on 2026/27 Contractual Framework commence appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (27/02/2026) confirmed the following list of price concessions for February 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.  [...]

The post February 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

From 1 June 2026, the Manage Your Service (MYS) will be the only route to notify ICBs of temporary suspensions/closures. This week, NHS England announced that it was giving advance notice of changes to the approved manner of reporting temporary suspensions of service or likely temporary suspensions of service (temporary closures) to ICBs. The changes [...]

The post Changes to the reporting of Temporary Suspensions appeared first on Community Pharmacy England.

Community Pharmacy England is taking steps to tackle inappropriate EPS pharmacy nomination practices and service direction, which contravene the principles of patient choice. Since concerns around certain IT functionality allowing automatic re-nomination (without patient consent) and the direction of services were first raised last year, our Regulatory and IT experts have been working to address [...]

The post Clamping down on inappropriate EPS nomination and service direction appeared first on Community Pharmacy England.